441 material Form 8-K filings that 376 companies we cover made with the SEC in June 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
General Mills reported fiscal 2025 fourth-quarter net sales of $4.6 billion, down 3 percent, and diluted EPS of $0.53, down 46 percent. For the full year, net sales were $19.5 billion, down 2 percent, and diluted EPS was $4.10, down 5 percent. The company expects fiscal 2026 adjusted diluted EPS to fall 10 to 15 percent in constant currency, as it increases spending on consumer value and brand investment.
Q4 net sales of $4.6 billion, down 3 percent; diluted EPS of $0.53, down 46 percent
Full-year net sales of $19.5 billion, down 2 percent; diluted EPS of $4.10, down 5 percent
Fiscal 2026 adjusted diluted EPS expected to be down 10 to 15 percent in constant currency from $4.21
Quarterly dividend raised 2 percent to $0.61 per share, payable August 1, 2025
DoubleVerify updated its guidance for the second quarter and full year 2025 in a press release furnished with an 8-K on June 11, 2025, the day of its Innovation Day event. The filing gives new ranges and growth figures but does not state the prior guidance, so the direction of the change cannot be determined from the filing.
Second quarter 2025 revenue guidance of $180 million to $184 million, a 17% year-over-year increase at the midpoint
Second quarter 2025 Adjusted EBITDA guidance of $52 million to $56 million, a 30% margin at the midpoint
Full-year 2025 guidance calls for revenue growth of approximately 13% year-over-year and an Adjusted EBITDA margin of approximately 32%
Innovation Day webcast scheduled for June 11, 2025, at 1:00 p.m. ET
Victoria's Secret & Co. reported first quarter 2025 net sales of $1.353 billion, above its guidance range of $1.30 billion to $1.33 billion but flat with the prior year, and a net loss of $2 million, or $0.02 per diluted share. It cut its full-year 2025 adjusted operating income forecast to $270 million to $320 million from $300 million to $350 million, citing an updated estimated net tariff impact of about $50 million, while keeping its full-year net sales forecast of $6.2 billion to $6.3 billion. The lower profit outlook matters to shareholders because it reduces the company's expected earnings for the year even though first quarter results beat its own expectations.
Q1 2025 net sales were $1.353 billion, above the guidance range of $1.30 billion to $1.33 billion and flat versus $1.359 billion a year earlier.
Q1 2025 adjusted operating income was $32 million, above the $10 million to $30 million guidance range, but down from $40 million a year earlier.
Full-year 2025 adjusted operating income guidance is now $270 million to $320 million, versus the prior $300 million to $350 million.
Second quarter 2025 net sales are forecast at $1.380 billion to $1.410 billion, with adjusted operating income of $15 million to $35 million.
Academy Sports and Outdoors reported first-quarter fiscal 2025 net sales of $1.35 billion, down 0.9%, with comparable sales down 3.7%. Diluted GAAP earnings per share fell to $0.68 from $1.01, and the company widened its full-year comparable sales guidance and changed its EPS range, lowering the low end while raising the high end.
Net income was $46.1 million versus $76.5 million a year earlier; diluted EPS was $0.68 versus $1.01.
Fiscal 2025 comparable sales guidance widened to -4% to +1%, from -2% to +1%.
Fiscal 2025 GAAP diluted EPS guidance is $5.10 to $5.90, versus the prior $5.40 to $5.85.
The company declared a quarterly dividend of $0.13 per share, payable July 17, 2025.
Vail Resorts reported fiscal third-quarter results for the period ended April 30, 2025, with net income attributable to the company up to $392.8 million from $362.0 million a year earlier. The company also lowered its fiscal 2025 outlook, now expecting net income of $264 million to $298 million and Resort Reported EBITDA of $831 million to $851 million, citing lower-than-expected lift ticket visitation in spring and one-time costs tied to the CEO transition.
Q3 net income attributable to Vail Resorts was $392.8 million, or $10.54 per diluted share, versus $362.0 million, or $9.54 per diluted share, a year earlier.
Resort Reported EBITDA was $647.7 million, down $6.6 million, or 1.0%, from the prior year, while Resort net revenue rose $12.3 million to $1,295.4 million.
Updated fiscal 2025 guidance: net income of $264 million to $298 million and Resort Reported EBITDA of $831 million to $851 million, including an estimated $9 million of CEO transition costs.
The Board declared a quarterly dividend of $2.22 per share, payable July 9, 2025, and increased the buyback authorization by 1.5 million shares to approximately 2.8 million.
PVH reported first quarter revenue of $1.984 billion, up 2% and above its guidance, but posted a GAAP loss of $(0.88) per share after a $480 million noncash impairment charge. The company reaffirmed its full-year revenue outlook but lowered its non-GAAP EPS projection to $10.75 to $11.00 from $12.40 to $12.75, citing tariffs and a challenging consumer backdrop.
Q1 revenue rose 2% to $1.984 billion, above guidance of flat to a 2% decrease.
Q1 GAAP EPS was $(0.88); non-GAAP EPS was $2.30, above guidance of $2.10 to $2.25.
Full-year non-GAAP EPS outlook cut to $10.75 to $11.00 from $12.40 to $12.75; revenue outlook reaffirmed.
Projected full-year non-GAAP operating margin is about 8.5%, versus 10.0% in 2024; tariffs carry an unmitigated impact of about $1.05 per share.
ANI Pharmaceuticals filed its investor presentation for the Jefferies Global Healthcare Conference, where CEO Nikhil Lalwani will speak on June 4, 2025. The slides restate 2025 guidance issued on May 9, 2025, which the company describes as its second guidance raise of the year, and they report first-quarter 2025 revenue and profit growth. The filing presents previously disclosed figures rather than new results, but the guidance increase is relevant to shareholders.
2025 net revenue guidance is $768 million to $793 million, up from $756 million to $776 million previously.
2025 adjusted non-GAAP EBITDA guidance is $195 million to $205 million, up from $190 million to $200 million; adjusted diluted EPS guidance is $6.27 to $6.62, up from $6.12 to $6.49.
First-quarter 2025 total revenue was $197 million, up 43% year over year, and adjusted non-GAAP EBITDA was $51 million, up 35%.
Q1 ILUVIEN and YUTIQ revenue of $16 million was temporarily affected by factors the company listed, including sales force turnover; the company said demand accelerated in Q2 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.